Lv4
410 积分 2022-08-03 加入
Targeting PFKFB4 Biomimetic Codelivery System Synergistically Enhances Ferroptosis to Suppress Small Cell Lung Cancer and Augments the Efficacy of Anti‐PD‐L1 Immunotherapy
19天前
已完结
Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular Carcinoma
19天前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
26天前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
27天前
已完结
Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor
1个月前
已完结
Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer
1个月前
已完结
Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer
1个月前
已完结
Discovery of BW710 as a Potent, Selective and Orally Bioavailable Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitor
1个月前
已完结
P0636 Impact of obefazimod treatment on histologic and combined histologic and endoscopic outcomes in patients with moderately to severely active ulcerative colitis: results from the Phase 2b open-label maintenance study
1个月前
已完结
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
1个月前
已完结
皖公网安备34019202002308
